Claudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancer

M Mosley, J Knight, A Neesse, P Michl… - Journal of Nuclear …, 2015 - Soc Nuclear Med
The expression of claudin-4, a protein involved in tight junction complexes, is widely
dysregulated in epithelial malignancies. Claudin-4 is overexpressed in several premalignant …

Radiolabeled cCPE peptides for SPECT imaging of claudin-4 overexpression in pancreatic cancer

JB Torres, M Mosley, S Koustoulidou… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Overexpression of tight-junction protein claudin-4 has been detected in primary and
metastatic pancreatic cancer tissue and is associated with better prognosis in patients …

Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target

LS Nichols, R Ashfaq… - American journal of …, 2004 - academic.oup.com
We performed a comprehensive immunohistochemical evaluation of claudin 4 protein
expression in paraffin-embedded tissue samples from 72 patients with primary infiltrating …

[HTML][HTML] Imaging of claudin-4 in pancreatic ductal adenocarcinoma using a radiolabelled anti-claudin-4 monoclonal antibody

JB Torres, JC Knight, MJ Mosley, V Kersemans… - Molecular imaging and …, 2018 - Springer
Purpose Despite its widespread use, the positron emission tomography (PET) radiotracer 2-
deoxy-2-[18 F] fluoro-D-glucose ([18 F] FDG) has been shown in clinical settings to be …

Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions

A Neesse, A Hahnenkamp, H Griesmann, M Buchholz… - Gut, 2013 - gut.bmj.com
Objectives Novel imaging methods based on specific molecular targets to detect both
established neoplasms and their precursor lesions are highly desirable in cancer medicine …

[HTML][HTML] Convenient Preparation of 18F-Labeled Peptide Probes for Potential Claudin-4 PET Imaging

L Feni, MA Omrane, M Fischer, BD Zlatopolskiy… - Pharmaceuticals, 2017 - mdpi.com
Since pancreatic cancer is often diagnosed in a late state of cancer development, diagnostic
opportunities allowing early disease detection are highly sought after. As such, cancer …

[HTML][HTML] Development of a CLDN18. 2-targeting immuno-PET probe for non-invasive imaging in gastrointestinal tumors

Y Chen, X Hou, D Li, J Ding, J Liu, Z Wang… - Journal of …, 2023 - Elsevier
Abstract Claudin18. 2 (CLDN18. 2) is a tight junction protein that is overexpressed in a
variety of solid tumors such as gastrointestinal cancer and oesophageal cancer. It has been …

[HTML][HTML] Claudin3 is localized outside the tight junctions in human carcinomas

M Corsini, A Ravaggi, F Odicino, AD Santin, C Ravelli… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Claudin3 is an integral component of the tight junction proteins in polarized epithelia. The
expression of claudin3 was assessed in epithelial-derived tumors using Oncomine …

A cCPE‐based xenon biosensor for magnetic resonance imaging of claudin‐expressing cells

A Piontek, C Witte, H May Rose… - Annals of the New …, 2017 - Wiley Online Library
The majority of malignant tumors originate from epithelial cells, and many of them are
characterized by an overexpression of claudins (Cldns) and their mislocalization out of tight …

[HTML][HTML] Monitoring breast tumor lung metastasis by U-SPECT-II/CT with an integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2

Y Zhou, G Shao, S Liu - Theranostics, 2012 - ncbi.nlm.nih.gov
Purpose: The purpose of this study was to evaluate the capability of u-SPECT-II/CT to
monitor the progression of breast cancer lung metastasis using 99m Tc-3P-RGD 2 as a …